Andromeda raises A$23M and launches Genesis Abi for aged care

Andromeda Robotics raised A $23 million in Series A funding and launched Genesis Abi, the next-generation version of its companion humanoid for aged care. The round was led by Forerunner Ventures, with participation from Rethink Impact, Artesian, Main Sequence, Visible Ventures and Trampoline, alongside returning investors Purpose Ventures and Startmate. The funding valued the Melbourne company at A $100 million and supports expansion into the United States, production scaling and hiring across Australia and the US.

The Company

Andromeda Robotics was founded in 2022 by Grace Brown and Yan Chen, with Brown’s own experience of loneliness during Melbourne’s COVID lockdowns shaping the company’s direction. Instead of building a humanoid around factory work, logistics or physical labour, Andromeda built Abi around companionship, emotional interaction and care-team support in aged care and assisted living environments.

The company’s public positioning is specific. Abi is designed to help care teams provide one-to-one companionship, multilingual conversation and small group activities such as singing, dancing, games and conversation. Andromeda says Abi can recognise faces, understand and express emotions, remember conversations from days or months earlier, and interact with residents based on personal cues such as preferred language, daily prayers or familiar memories.

The Product

Abi is a colourful social humanoid built for human connection rather than mechanical task execution. The robot is about 110 centimetres tall, anthropomorphic, and designed with arms, legs and a deliberately friendly character. Public descriptions from Andromeda and its investors frame Abi as a care companion that can support residents through conversation, games, music, dancing, patient listening and personalised social engagement.

Genesis Abi is the upgraded version tied to the Series A announcement. Andromeda says the new model is more autonomous, can be scheduled by care teams, can navigate a home independently, and can support staff by spending one-to-one time with residents, leading group activities and speaking with residents in their preferred language. The company says Abi supports conversation in up to 90 languages.

The Round

The company says the funding will help fast-track work in Australia, grow the team and production, bring Abi to more aged care partners, and begin work in the US, starting with aged care. Brown said the US buildout includes hiring creative and animation robotics specialists, which fits the company’s emphasis on character, social interaction and emotional design rather than industrial manipulation.

Investor materials from Main Sequence describe Abi as a humanoid designed to support carers rather than replace them, using large language models, computer vision and embodied AI to remember resident preferences, hold conversations and initiate activities. That investor framing is useful because it places Andromeda’s robot inside a care-labour constraint, where the product is not measured by boxes moved or parts assembled, but by whether it can create repeatable engagement in environments where staff time is limited.

Maturity

Andromeda is past the pure prototype stage. Abi has been piloted and used with aged care providers in Australia, with Andromeda listing mecwacare and Medical & Aged Care Group executives as public customer references. The company has disclosed a Series A, a next-generation robot, first aged-care deployment plans for Genesis Abi, US expansion plans and a defined care-sector use case. It has not published fleet size, contract structure, retention data, production output or independent clinical outcomes. The next stronger signal is whether Genesis Abi converts care-home engagement into repeatable commercial deployments across Australia and the US.

Have a robotics update Korthos should review? Send news, deployments, product releases, funding rounds, research, or media to tips@korthos.xyz or reach out on X at @agkorthos.